Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia

Cited by (496)

Items 201–300 of 496

1. Achilles tendon thickening is associated with disease severity and plaque vulnerability in patients with coronary artery disease
   Takuya Hashimoto, Yoshiyasu Minami, Ryota Kakizaki, Teruyoshi Nemoto, Kazuhiro Fujiyoshi, Kentaro Meguro, Takao Shimohama, Taiki Tojo, Junya Ako · 2018 · Journal of clinical lipidology
2. Selective screening for familial hypercholesterolemia in Austrian children - first year results
   Alexandra Kreissl, N.-K. Walleczek, Pinky Rose Espina, Ulrike Hallwirth, Susanne Greber‐Platzer · 2019 · BMC Pediatrics
3. Diagnosis Scoring for Clinical Identification of Children With Heterozygous Familial Hypercholesterolemia
   Pascale Benlian, Anne Turquet, Fabrice Carrat, Sabine Amsellem, Lydie Sanchez, Dorothée Briffaut, Jean Philippe Girardet · 2009 · Journal of Pediatric Gastroenterology and Nutrition
4. Genetic variation and lipid metabolism: Modulation by dietary factors
   José María Ordovás, Dolores Corella · 2005 · Current Cardiology Reports
5. Coste-efectividad del manejo de la hipercolesterolemia familiar con estrategias de tratamiento preventivo basadas en atorvastatina
   Rodrigo Alonso K, Jaime Fernández de Bobadilla, Ignacio Méndez, Pablo Lázaro, Nelva Mata, Pedro Mata · 2008 · Revista Española de Cardiología
6. Selective and Regenerable Surface Based on β-Cyclodextrin for Low-Density Lipoprotein Adsorption
   Fei Yu Fang, Xiao‐Jun Huang, Yizong Guo, Xiao Hong, Huimin Wu, Rong Liu, Dajing Chen · 2018 · Langmuir
7. Inflammatory Biomarkers for Cardiovascular Risk Stratification in Familial Hypercholesterolemia
   Afsane Bahrami, Luca Liberale, Željko Reiner, Federico Carbone, Fabrizio Montecucco, Amirhossein Sahebkar · 2020 · Reviews of physiology, biochemistry and pharmacology
8. Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry
   Rebeca Lorca, Andrea Aparicio, Elías Cuesta‐Llavona, Isaac Pascual, Alejandro Junco-Vicente, Sergio Hevia, Francisco Villazón González, Daniel Hernández‐Vaquero, J.J.R. Reguero, César Morı́s et al. · 2020 · Journal of Clinical Medicine
9. Hypercholesterolemia and LDL Apheresis
   F. Morelli, Paolo Carlier, Gabriella Giannini, M.C. De Luigi, Anna Maria Dejana, Maria Rosaria Ruzzenenti, M. Valbonesi · 2005 · The International Journal of Artificial Organs
10. Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: A creative approach by a cardiologist in a developing country
    Khoo Kah Lin, Michael M. Page, Yin Mei Liew, Joep C. Defesche, Gerald Francis Watts · 2016 · Journal of clinical lipidology
11. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia – a preliminary report
    C. S. Paththinige, Jayantha Rajapakse, GR Constantine, Kai Ping Sem, Roshni Rebecca Singaraja, Rohan W. Jayasekara, Vajira H. W. Dissanayake · 2018 · Lipids in Health and Disease
12. Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment
    Kurt Derfler, Sabine Steiner, Helmut F. Sinzinger · 2015 · Wiener klinische Wochenschrift
13. Using the experiences of people with familial hypercholesterolaemia to help reduce the risk of cardiovascular disease: a qualitative systematic review
    Lauretta A. Muir, Peter Myles George, Lisa Whitehead · 2012 · Journal of Advanced Nursing
14. An Update on the Clinical Development of Proprotein Convertase Subtilisin Kexin 9 Inhibitors, Novel Therapeutic Agents for Lowering Low‐Density Lipoprotein Cholesterol
    Hua Ling, Tammy L. Burns, Daniel E. Hilleman · 2013 · Cardiovascular Therapeutics
15. Familial hypercholesterolaemia in patients with ischaemic stroke or transient ischaemic attack
    Thomas Toell, Lukas Mayer‐Suess, Raimund Pechlaner, Stefan Krebs, Karin Willeit, C. Lang, Christian Boehme, Barbara Prantl, Michael Knoflach, Julia Ferrari et al. · 2017 · European Journal of Neurology
16. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight
    Lucía Baila-Rueda, Ana Cenarro, Itziar Lamíquiz-Moneo, Sofía Pérez‐Calahorra, Ana M. Bea, Victoria Marco-Benedí, Estíbaliz Jarauta, Rocío Mateo‐Gállego, Fernando Civeira · 2017 · The Journal of Nutritional Biochemistry
17. Prevalence of heterozygous familial hypercholesterolemia and combined hyperlipidemia phenotype in very young survivors of myocardial infarction and their association with the severity of atheromatous burden
    Lοukianos S. Rallidis, Nikolaos Kosmas, George Tsirebolos, Maria Rallidi, Estela Kiouri, Dionisios Kalpakos · 2019 · Journal of clinical lipidology
18. Comparison of DNA Array Platform vs DNA Sequencing as Genetic Diagnosis Tools for Familial Hypercholesterolemia
    Diego Tejedor, Sergio Castillo, Pilar Mozas, Elisa Jiménez, Mónica López, María Teresa Tejedor, Marta Artieda, Rodrigo Alonso K, Pedro Mata, Laureano Simón et al. · 2006 · Clinical Chemistry
19. Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts
    Joshua W. Knowles, Neil J. Stone, Christie Mitchell Ballantyne · 2015 · The American Journal of Cardiology
20. Consenso de expertos sobre la detección y el manejo clínico de la hipercolesterolemia familiar
    L. Masana, Fernando Civeira, Juan Pedro‐Botet, Isabel de Castro-Orós, Miguel Pocovı́, Núria Plana, Rocío Mateo‐Gállego, Estíbaliz Jarauta, Àngels Pedragosa · 2013 · Clínica e Investigación en Arteriosclerosis
21. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)
    P. Elliott Miller, Seth Shay Martin, Peter Paul Toth, Raul Dias Santos, Michael Joseph Blaha, Khurram Nasir, Salim S. Virani, Wendy S. Post, Roger Scott Blumenthal, Steven Richard Jones · 2015 · Journal of clinical lipidology
22. A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?
    Gerald Francis Watts, DAVID R. SULLIVAN, Frank M. VAN BOCKXMEER, Nicola Kazia Poplawski, Ian R Hamilton‐Craig, Peter Marshall Clifton, Richard Charles O’Brien, Warrick Bishop, Peter Myles George, Christopher Semsarian et al. · 2012 · Heart Lung and Circulation
23. Cosegregation of serum cholesterol with cholesterol intestinal absorption markers in families with primary hypercholesterolemia without mutations in LDLR, APOB, PCSK9 and APOE genes
    Lucía Baila-Rueda, M.R. Pérez-Ruiz, Estíbaliz Jarauta, María Teresa Tejedor, Rocío Mateo‐Gállego, Itziar Lamíquiz-Moneo, Isabel de Castro-Orós, Ana Cenarro, Fernando Civeira · 2016 · Atherosclerosis
24. Carotid intima-media thickness as a screening tool in cardiovascular primary prevention
    Antonio Luis Aguilar-Shea, Cristina Gallardo-Mayo, Sofía Garrido-Elustondo, Elpidio Calvo Manuel, José Luis Zamorano-Gómez · 2010 · European Journal of Clinical Investigation
25. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease
    Barak Zafrir, Ayman Jubran, Gil Lavie, David A. Halon, Moshe Y. Flugelman, Chen Shapira · 2017 · Circulation Journal
26. A model of care for familial hypercholesterolaemia: key role for clinical biochemistry.
    Gerald Francis Watts, DAVID R. SULLIVAN, Frank M. VAN BOCKXMEER, Nicola Kazia Poplawski, Ian R Hamilton‐Craig, Peter Marshall Clifton, Richard Charles O’Brien, Peter Myles George, John R. Burnett · 2012 · Europe PMC (PubMed Central)
27. Prise en charge des hypercholestérolémies de l’enfant : recommandations du Comité de nutrition de la Société française de pédiatrie et de la Nouvelle société française d’athérosclérose
    J.-P. Girardet, G. Luc, Daniel Rieu, Éric Bruckert, Dominique Darmaun, Michel Farnier · 2010 · Archives de Pédiatrie
28. Asociación de la presencia de placa carotídea en la aparición de eventos cardiovasculares en pacientes con hipercolesterolemias genéticas
    Ana M. Bea, Fernando Civeira, Estíbaliz Jarauta, Itziar Lamíquiz-Moneo, Sofía Pérez‐Calahorra, Victoria Marco-Benedí, Ana Cenarro, Rocío Mateo‐Gállego · 2016 · Revista Española de Cardiología
29. Guidance on the management of familial hypercholesterolaemia in Hong Kong: an expert panel consensus viewpoint
    Brian Tomlinson, Juliana C.N. Chan, W B Chan, W. Chen, Francis CC Chow, SK Li, Alice P.S. Kong, Ronald C.W., David CW Siu, K. C. B. Tan et al. · 2018 · Hong Kong Medical Journal
30. Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
    Ågot Lia Amundsen, Janette Khoury, Per Morten Sandset, Ingebjørg Seljeflot, Leiv Ose, Serena Tonstad, Tore Henriksen, Kjetil Retterstøl, Per Ole Iversen · 2006 · Thrombosis Research
31. Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35–75 years: Results from China PEACE Million Persons Project
    Haobo Teng, Yan Gao, Chaoqun Wu, Haibo Zhang, Xin Zheng, Jiapeng Lu, Yán Li, Yanping Wang, Yan Gao, Yang Yang et al. · 2022 · Atherosclerosis
32. Control de las hiperlipemias en la práctica clínica
    Rodrigo Alonso K, Nelva Mata Pariente, Pedro Mata López · 2006 · Revista Española de Cardiología Suplementos
33. Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel
    Bojko B. Bjelakovic, Claudia Stefanutti, Željko Reiner, Gerald Francis Watts, Patrick M. Moriarty, DAVID P. MARAIS, Kurt Widhalm, Hofit Cohen, Mariko Harada‐Shiba, Maciej Banach · 2021 · Journal of Clinical Medicine
34. Prevalence and pharmacologic management of familial hypercholesterolemia in an unselected contemporary cohort of patients with stable coronary artery disease
    Leonardo De Luca, Marcello Arca, Pier Luigi Temporelli, Furio Colivicchi, Lucio Gonzini, Donata Lucci, Biagio Bosco, Mariella Callerame, G.V. Lettica, Andrea Di Lenarda et al. · 2018 · Clinical Cardiology
35. Colesevelam
    Caroline M. Perry · 2010 · Pediatric Drugs
36. Encouraging appropriate treatment for familial hypercholesterolemia
    Paul Nathan Hopkins · 2010 · Clinical Lipidology
37. Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: Application of two different apheresis techniques in childhood
    Songül Gökay, Mustafa Kendırcı, Leylagül Kaynar, Musa Solmaz, Aysun Çetin, Fatih Kardaş, Pembe Soylu Üstkoyuncu · 2015 · Transfusion and Apheresis Science
38. Hipercolesterolemia familiar: artículo de revisión
    Alonso Merchán, Álvaro J. Ruiz, Rafael Campo, Carlos Enrique Prada, Juan Manuel Toro, Róbinson Sánchez, Juan Esteban Gómez‐Mesa, Nicolás I. Jaramillo, Dora Ines Molina, Hernando Vargas‐Uricoechea et al. · 2016 · Revista Colombiana de Cardiología
39. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention
    Hideki Kitahara, Naoto Mori, Yuichi Saito, Takashi Nakayama, Yoshihide Fujimoto, Yoshio Kobayashi · 2019 · Heart and Vessels
40. LDLR promotes growth and invasion in renal cell carcinoma and activates the EGFR pathway
    Guiming Zhang, Wei Chen, Yu Yao, Lei Luo, Lijiang Sun · 2021 · Neoplasma
41. Familial hypercholesterolemia – treatment update in children, systematic review
    Sabina Ziółkowska, Noëlle Kijek, Iga Zendran, Ewa Szuster, Ewa Barg · 2022 · Pediatric Endocrinology Diabetes and Metabolism
42. Overexpression of the CXCL3 gene in response to oxidized low-density lipoprotein is associated with the presence of tendon xanthomas in familial hypercholesterolemia
    Paula Martín‐Fuentes, Fernando Civeira, María Solanas-Barca, A.L. García-Otín, Estíbaliz Jarauta, Ana Cenarro · 2009 · Biochemistry and Cell Biology
43. Estudio del componente genético de la cardiopatía isquémica: de los estudios de ligamiento al genotipado integral del genoma
    Roberto Elosúa, Carla Lluís-Ganella, Gavin Lucas · 2009 · Revista Española de Cardiología Suplementos
44. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia
    Christina Taylan, Andrea Schlune, Thomas Meißner, Karolis Ažukaitis, Floris E.A. Udink ten Cate, Lutz Thorsten Weber · 2016 · Journal of clinical lipidology
45. Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL
    Lοukianos S. Rallidis, Estela Kiouri, Ανδρέας Κατσιμάρδος, Christos Kotakos · 2018 · Atherosclerosis
46. The efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experience
    Murat Albayrak, Abdülkerim Yıldız, Neşe Ateş, Çiğdem Pala · 2018 · Transfusion and Apheresis Science
47. INTERIM Guidelines for the Diagnosis and Management of Familial Hypercholesterolaemia
    DAVID R. SULLIVAN, Ian R Hamilton‐Craig, Frank van Bockxmeer, Gerald Francis Watts · 2012 · Heart Lung and Circulation
48. Examining barriers to cascade screening for familial hypercholesterolemia in the United States
    Rolf L. Andersen, Lars H. Andersen · 2015 · Journal of clinical lipidology
49. Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?
    Ines Krass, A. T. Walker, Gerald Francis Watts · 2012 · International Journal of Clinical Pharmacy
50. Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia
    Leonardo Celeste Mangili, Otávio Celeste Mangili, Márcio Sommer Bittencourt, Marcio Hiroshi Miname, Paulo H. N. Harada, Leonardo Mandalho Lima, Carlos Eduardo Rochitte, Raul Dias Santos · 2016 · Atherosclerosis
51. Percutaneous Coronary Intervention in Familial Hypercholesterolemia Is Understudied
    Leo D. J. Ungar, David Surendran Sanders, Brian Becerra, Ailin Barseghian · 2018 · Frontiers in Cardiovascular Medicine
52. A Novel Modified System of Simplified Chinese Criteria for Familial Hypercholesterolemia (SCCFH)
    Ye‐Xuan Cao, Di Sun, Huihui Liu, Jing‐Lu Jin, Sha Li, Yuan‐Lin Guo, Na‐Qiong Wu, Cheng‐Gang Zhu, Ying Gao, Qiu‐Ting Dong et al. · 2019 · Molecular Diagnosis & Therapy
53. Impact of statin therapy on LDL and non-HDL cholesterol levels in subjects with heterozygous familial hypercholesterolaemia
    Elisenda Climent, Victoria Marco-Benedí, David Benaiges, Xavier Pintó, Manuel Suárez Tembra, Núria Plana, Hannia Lafuente, Emilio Ortega-Martínez de Victoria, Ángel Brea-Hernando, Àlex Vila et al. · 2021 · Nutrition Metabolism and Cardiovascular Diseases
54. Diagnóstico y tratamiento de la hipercolesterolemia familiar en España: documento de consenso
    Pedro Mata, Rodrigo Alonso K, Antonio Ruiz, José Ramón González‐Juanatey, Lina Badimón, José Luis Díaz-Díaz, María Teresa Múñoz, Ovidio Muñiz-Grijalvo, Enrique Galve, Luis Irigoyen et al. · 2014 · Medicina de Familia SEMERGEN
55. The Spectrum of Low-Density Lipoprotein Receptor Mutations in a Large Turkish Cohort of Patients with Familial Hypercholesterolemia
    Ayberk Türkyılmaz, Erdal Kurnaz, Ceren Alavanda, Oğuzhan Yaralı, Emine Kartal Baykan, Dilek Gogaş Yavuz, Atilla Çayır, Pınar Ata · 2021 · Metabolic Syndrome and Related Disorders
56. Genetic Spectrum of Familial Hypercholesterolaemia in the Malaysian Community: Identification of Pathogenic Gene Variants Using Targeted Next-Generation Sequencing
    Aimi Zafira Razman, Yung-An Chua, Noor Alicezah Mohd Kasim, Alyaa Al-Khateeb, Siti Hamimah Sheikh Abdul Kadir, Siti Azma Jusoh, Hapizah Mohd Nawawi · 2022 · International Journal of Molecular Sciences
57. Burdock fructooligosaccharide ameliorates the hypercholesterolemia and vascular inflammation in mice by regulating cholesterol homeostasis and anti-inflammatory properties
    Ying Meng, Qunfei Ma, Xuan Xu, Liting Feng, Qiang Chen, Yiru Chen, Zhang Li, Chunyan Liu, Kaoshan Chen · 2023 · Journal of Functional Foods
58. Genetic screening for homozygous and heterozygous familial hypercholesterolemia
    Francisco Antônio Helfenstein Fonseca · 2010 · The Application of Clinical Genetics
59. Estatinas: Características y Efectos sobre el Control Lipídico en el Niño y Adolescente Obeso
    Emilio González Jiménez, J. Álvarez Ferré · 2011 · Revista Clínica de Medicina de Familia
60. The removal from plasma of chylomicrons and remnants is reduced in heterozygous familial hypercholesterolemia subjects with identified LDL receptor mutations: Study with artificial emulsions
    Márcia Maria Carneiro, Marcio Hiroshi Miname, Ana Carolina Moron Gagliardi, Carolina Pereira, Alexandre C. Pereira, José Eduardo Krieger, Raul Cavalcante Maranhão, Raul Dias Santos · 2011 · Atherosclerosis
61. 2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document
    Massimo Volpe, Roberto Volpe, Giovanna Gallo, Vivianne Presta, Giuliano Tocci, Emanuela Folco, Andrea P. Peracino, Elena Tremoli, Bruno Trimarco · 2017 · High Blood Pressure & Cardiovascular Prevention
62. Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia
    Itziar Lamíquiz-Moneo, M.R. Pérez-Ruiz, Estíbaliz Jarauta, María Teresa Tejedor, Ana M. Bea, Rocío Mateo‐Gállego, Sofía Pérez‐Calahorra, Lucía Baila-Rueda, Victoria Marco-Benedí, Isabel de Castro-Orós et al. · 2017 · Revista Española de Cardiología (English Edition)
63. NHG-Standpunt Diagnostiek en behandeling van familiaire hypercholesterolemie
    Edmond Walma, Tj Wiersma · 2009 · Bohn Stafleu van Loghum eBooks
64. Longitudinal Control of Lipid Levels in Patients With Premature Coronary Artery Disease
    Diana N. Vikulova, Danielle Pinheiro-Muller, Carlos H. Rojas‐Fernandez, Francois Leblond, Simon Neil Pimstone, Liam R. Brunham · 2023 · JACC Advances
65. A systematic approach for successful PCSK9 inhibitor prescribing in clinical practice
    Thomas Knickelbine, Lori Jia, Susan White, Ross Garberich, Sandra Oberembt, Samantha Wills, Michael D. Miedema, Emmanouil S. Brilakis · 2019 · Journal of clinical lipidology
66. POTENTIAL ROLE OF A NUTRACEUTICAL SPICE (ALLIUM HIRTIFOLIUM) IN REDUCTION OF ATHEROSCLEROTIC PLAQUES
    Mahmoud Rafieian‐Kopaei, Mahtab Keshvari, Sedigheh Asgary, Maryam Salimi, Esfandiar Heidarian · 2013 · DOAJ (DOAJ: Directory of Open Access Journals)
67. Regional and National Familial Hypercholesterolemia Registries: Present International Application, Importance, and Needs for Canada
    Ahmad J Al-Sarraf, Matt Allard, Michal Martinka, Jiri J Frohlich · 2012 · Canadian Journal of Cardiology
68. Functional analysis of new 3′ untranslated regions genetic variants in genes associated with genetic hypercholesterolemias
    Flor M. Pérez-Campo, Isabel de Castro-Orós, Alicia Noriega, Montserrat Cofán, Itziar Lamíquiz-Moneo, Ana Cenarro, Emilio Ros, Fernando Civeira, Miguel Pocovı́, José Carlos Rodríguez-Rey · 2017 · Journal of clinical lipidology
69. Variantes de un solo nucleótido asociadas con la hipercolesterolemia poligénica en familias diagnosticadas de hipercolesterolemia familiar
    Itziar Lamíquiz-Moneo, M.R. Pérez-Ruiz, Estíbaliz Jarauta, María Teresa Tejedor, Ana M. Bea, Rocío Mateo‐Gállego, Sofía Pérez‐Calahorra, Lucía Baila-Rueda, Victoria Marco-Benedí, Isabel de Castro-Orós et al. · 2017 · Revista Española de Cardiología
70. Investigating the association between familial hypercholesterolemia and perceived depression
    Nien‐Tzu Chang, Ta‐Chen Su · 2019 · Atherosclerosis Supplements
71. Aortic Valvular Disease in Elderly Subjects with Heterozygous Familial Hypercholesterolemia: Impact of Lipid-Lowering Therapy
    Victoria Marco-Benedí, Martín Laclaustra, J.M. Casado-Dominguez, Rosa Villa-Pobo, Rocío Mateo‐Gállego, Rosa M. Sánchez-Hernández, Marta Blanco Nuez, Emilio Ortega, Marta Sitges, Juan Pedro‐Botet et al. · 2019 · Journal of Clinical Medicine
72. Nuevas perspectivas en la medición del riesgo cardiovascular: exploraciones para detectar la aterosclerosis subclínica y marcadores de inflamación
    Consuelo Fernández‐Miranda, Xavier Pintó · 2007 · Medicina Clínica
73. Differential diagnosis of tendon tumors: xanthomas caused by hyperlipidemia in children
    Ilona Reichwaldt, Jozef Zustin, Katharina Wenke, Ina Ridderbusch · 2010 · Journal of Pediatric Surgery
74. Benefits and risks assessment of simvastatin in familial hypercholesterolaemia
    Rodrigo Alonso K, Nelva Mata, Pedro Mata · 2005 · Expert Opinion on Drug Safety
75. Carotid artery plaques – Are risk factors the same in men and women with familial hypercholesterolemia?
    Małgorzata Waluś‐Miarka, Danuta Czarnecka, Małgorzata Kloch‐Badełek, Wiktoria Wojciechowska, Maria Kapusta, Maciej Tadeusz Malecki · 2017 · International Journal of Cardiology
76. A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family
    Hongyan Shu, Jingwei Chi, Jing Li, Wei Zhang, Wenshan Lv, Jie Wang, Yujie Deng, Xu Hou, Yangang Wang · 2017 · PLoS ONE
77. How well can familial hypercholesterolemia be identified in an electronic health record database?
    Katherine E. Mues, Alina Bogdanov, Keri L. Monda, Larisa Yedigarova, Alexander Liede, Lee Kallenbach · 2018 · Clinical Epidemiology
78. Old challenges and new opportunities in the clinical management of heterozygous familial hypercholesterolemia (HeFH): The promises of PCSK9 inhibitors
    Marcello Arca · 2016 · Atherosclerosis
79. Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytes
    Waleria Toledo Fonzar, Francisco Antônio Helfenstein Fonseca, Henrique Andrade R. Fonseca, Tuany P. Silva, Alfredo Augusto Eyer Rodrigues, Daniela Teixeira, Mayari Eika Ishimura, Maria Esther Rochael Coste, Carolina Nunes França, Henrique Tria Bianco et al. · 2022 · Atherosclerosis Plus
80. Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice
    Branislav Vohnout, Ľubomíra Fábryová, Alexander Klabník, Michaela Kadurová, Karin Bálinth, Miriam Kozárová, Ingrid Bugáňová, Jana Sirotiaková, Katarı́na Rašlová · 2018 · Atherosclerosis
81. Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility
    Gui-Ming Zhang, Mengyun Wang, Ya-Nan Liu, Yao Zhu, Fangning Wan, Qing-Yi Wei, Dingwei Ye · 2017 · Carcinogenesis
82. Achilles tendon thickening is associated with higher incidence of adverse cardiovascular event in patients with coronary artery disease
    Takuya Hashimoto, Yoshiyasu Minami, Kiyoshi Asakura, Masahiro Katamine, Ayami Kato, Aritomo Katsura, Toshimitsu Sato, Yusuke Muramatsu, Ryota Kakizaki, Kazuhiro Fujiyoshi et al. · 2020 · Heart and Vessels
83. Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
    Estíbaliz Jarauta, Ana M. Bea, Victoria Marco-Benedí, Itziar Lamíquiz-Moneo · 2020 · Frontiers in Genetics
84. Role of ApoA1 on high-density lipoprotein: an intervention with plant sterols in patients with hypercholesterolemia.
    Ismael San Mauro Martín, Luis Collado Yurrita, María Ángeles Cuadrado Cenzual, María José Ciudad Cabañas, Paula Mendive Dubourdieu · 2014 · PubMed
85. Exploring Gaps of Family History Documentation in EHR for Precision Medicine -A Case Study of Familial Hypercholesterolemia Ascertainment.
    Saeed Mehrabi, Yanshan Wang, Donna M. Ihrke, Hongfang Liu · 2016 · PubMed Central
86. Hipercolesterolemia familiar en la infancia y la adolescencia: una realidad oculta
    Núria Plana, Cèlia Rodríguez-Borjabad, Daiana Ibarretxe, L. Masana · 2017 · Clínica e Investigación en Arteriosclerosis
87. CASCADE screening and registry of familial hypercholesterolemia in Iran: Rationale and design.
    Golnaz Vaseghi, Sina Arabi, Shaghayegh Haghjooy Javanmard, Mohammadreza Sabri, Masoumeh Sadeghi, Alireza Khosravi, Sonia Zarfeshani, Nizal Sarrafzadegan · 2019 · PubMed Central
88. Chondroitin sulfate-functionalized 3D hierarchical flower-type mesoporous silica with a superior capacity for selective isolation of low density lipoprotein
    Jian-Fang Cao, Xu Wang, Yaoyao Zhang, Yang Shu, Jianhua Wang · 2020 · Analytica Chimica Acta
89. Spectrum and Prevalence of Rare APOE Variants and Their Association with Familial Dysbetalipoproteinemia
    Blokhina, Anastasia V., Ershova, Alexandra I., Kiseleva, Anna V., Sotnikova, Evgeniia A., Zharikova, Anastasia A., Zaicenoka, Marija, Vyatkin, Yuri V., Ramensky, Vasily E., Kutsenko, Vladimir A., Garbuzova, Elizaveta V. et al. · 2024 · International Journal of Molecular Sciences
90. Pharmacotherapy of dyslipidemias in the adult population
    Giovanni Battista Vigna, R. Fellin · 2010 · Expert Opinion on Pharmacotherapy
91. Lipoprotein apheresis for the treatment of familial hypercholesterolemia
    Shahenaz Walji, Clare K. Y. Neuwirth, Gilbert R. Thompson · 2013 · Clinical Lipidology
92. Research Into the Genetic Component of Heart Disease: From Linkage Studies to Genome-Wide Genotyping
    Roberto Elosúa, Carla Lluís-Ganella, Gavin Lucas · 2009 · Revista Española de Cardiología
93. LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank
    Jasmine Gratton, Chris Finan, Aroon Dinesh Hingorani, Steve Eric Humphries, Marta Futema · 2022 · Frontiers in Genetics
94. [Risk management of cardiovascular disease through milk enriched with sterols in a young-adult population; randomized controlled clinical trial].
    Ismael San Mauro Martín, Luis Collado Yurrita, María José Ciudad Cabañas, María Ángeles Cuadrado Cenzual, Marta Hernández Cabría, María Elisa Calle Purón · 2014 · PubMed
95. Genetic Testing in Hyperlipidemia
    Ozlem Bilen, Yashashwi Pokharel, Christie Mitchell Ballantyne · 2015 · Cardiology Clinics
96. Uso de estatinas durante la infancia
    Leopoldo Tapia Ceballos, B. Picazo Angelín, C. Ruiz García · 2008 · Anales de Pediatría
97. Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia
    Itziar Lamíquiz-Moneo, Fernando Civeira, Rocío Mateo‐Gállego, Martín Laclaustra, Belén Moreno‐Franco, María Teresa Tejedor, Lourdes Palacios, César Martı́n, Ana Cenarro · 2020 · Revista Española de Cardiología (English Edition)
98. A Novel Mutation in Exon 4 of the Low Density Lipoprotein (LDL) Receptor Gene in an Iranian Familial Hypercholesterolemia Patient
    Pezhman Fard‐Esfahani, Cyrus Zeinali, Soghra Rouhi Dehboneh, Mohhammad Taghikhani, Shohreh Khatami · 2005
99. Manifestations of familial hypercholesterolaemia
    Melissa J Gillett, John R. Burnett · 2005 · Internal Medicine Journal
100. Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR/APOB/PCSK9/APOE mutations. Association with lipids and carotid atherosclerosis
     Lucía Baila-Rueda, Ana Cenarro, Itziar Lamíquiz-Moneo, Rocío Mateo‐Gállego, Ana M. Bea, Sofía Pérez‐Calahorra, Victoria Marco-Benedí, Fernando Civeira · 2016 · The Journal of Steroid Biochemistry and Molecular Biology